Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

RSS icon
Thumbnail

FDA warns of probable carcinogens in Zantac, other heartburn drugs

The FDA announced Sept. 13 it identified low levels of N-nitrosodimethylamine, or NDMA, in popular heartburn drugs including Zantac.

Thumbnail

Study adds to pool of evidence that paclitaxel-coated devices are safe

Contrary to a recent FDA advisory that acknowledged a late mortality signal with paclitaxel-coated and -eluting devices, a study published in the Journal of Endovascular Therapy found such stents safe in the long-term for treating femoropopliteal lesions in people with peripheral artery disease.

Thumbnail

Men with erectile dysfunction prone to heart disease, stroke

Men who struggle with erectile dysfunction—especially more severe cases—are at an increased risk of CHD, total heart disease, stroke and all-cause mortality, according to research published in the Journal of Sexual Medicine.

Thumbnail

FDA slams Juul for marketing e-cigarettes as ‘totally safe’

The FDA issued a warning letter to e-cigarette giant Juul early this week accusing the company of illegally promoting its vaping products as safer than cigarettes.

Thumbnail

Vitamin E could be the culprit behind vaping-related lung disease

Investigators from the New York State Department of Health believe they’ve identified the culprit behind the recent onslaught of vaping-related illnesses in the U.S., Health Exec reports.

Thumbnail

Men who live alone struggle with taking warfarin

Men who live on their own—but not women—struggle to take warfarin as directed, according to research presented Sept. 2 at the ESC Congress in Paris.

Smokers’ elevated CVD risk lingers for 10-15 years after quitting

It takes somewhere between 10 and 15 years—and possibly up to 25—after quitting tobacco for former heavy smokers’ CVD risk to revert to pre-smoking levels, according to a study published August 20 in JAMA.

Thumbnail

Reports of vaping-related lung injury climb to 120

Fifteen states have now reported more than 120 cumulative cases of vaping-related lung disease or injury, according to the results of a CNN survey of state health departments.

Displaying 545 - 552 of 1638

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.